Introduction to Psychedelics for the Treatment of Substance Use Disorder

Join the National Council for Mental Wellbeing's Substance Use Interest Group as they welcome Dr. Sandeep Nayak, Medical Director of the Johns Hopkins Center for Psychedelic & Consciousness Research, to explore the emerging science of using psychedelics in addiction treatment. This discussion will cover the historical context and evolution of the field, foundational information on psychedelic therapy for SUD, past and emerging research, the diverse cultural contexts in which psychedelics are used, and the current regulatory landscape for using psychedelics in addiction treatment. It will also delve into specific research findings on the use of psilocybin for reducing illicit opioid use, improving quality of life, smoking cessation and addressing comorbidity in depression and alcohol use.